Abbott Laboratories (ABT) Stock Price Today
Aura AI Summary
Key Stats
- $186.55BMarket Cap
- -Volume
- HealthSector
- $136.6252W High
- $82.5752W Low
- -Typical Hold Time
- $213.56BEnterprise Value
- 2.34%Div Yield
- -Trading Activity
Track Abbott Laboratories (ABT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $136.62, highlighting its annual price range. Buy and sell Abbott Laboratories shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Most Recent News
Yili hosts sustainability forum at World Dairy Conference, shaping post-2030 dairy industry future.
Yili Group held a sustainability forum on August 2, 2026, during the World Dairy Industry Conference in Hohhot, China, gathering over 200 global leaders to discuss sustainable development in dairy farming beyond 2030. The event highlighted Yili's lea...

Yili hosts global dairy sustainability forum, driving post-2030 green industry goals.
Yili Group organized a Sustainability Forum during the 2026 World Dairy Industry Conference in Hohhot, China, gathering over 200 international leaders to promote sustainable development in the dairy sector beyond 2030. The event highlighted Yili's le...

Halper Sadeh LLC investigates if shareholders of BZH, ACA, SYNA, CRNX get fair deals in recent sales.
Halper Sadeh LLC is investigating whether shareholders of Beazer Homes USA (BZH), Arcosa (ACA), Synaptics (SYNA), and Crinetics Pharmaceuticals (CRNX) are receiving fair treatment in their companies' recent sales. The law firm suspects insiders may g...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.